Psyched: LSD For Major Depression, Canada's Large Scale Psilocybin Macrodose Trial, Treatments For Autism Spectrum Disorder And Multiple Sclerosis And More
Psyched: LSD For Major Depression, Canada's Large Scale Psilocybin Macrodose Trial, Treatments For Autism Spectrum Disorder And Multiple Sclerosis And More
Psyched：用于重度抑郁症的迷幻药、加拿大大规模的 psilocybin 大剂量试验、自闭症谱系障碍和多发性硬化症的治疗方法等等
LSD Trial Study Shows Potential For Major Depression
LSD 试验研究显示可能出现重度抑郁症
Psychedelics biopharma company Mind Medicine Inc. (NASDAQ:MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a treatment of Major Depressive Disorder (MDD).
The double-blind Phase 2 study demonstrated "significant, rapid, durable and beneficial effects" on the mitigation of MDD symptoms. Read more HERE.
迷幻药生物制药公司 MindMedicine Inc 纳斯达克股票代码：MNMD）最近分享了来自迷幻药高级临床试验的积极头条数据 作为重度抑郁症（MDD）的治疗方法。
双盲2期研究表明，对缓解MDD症状有 “显著、快速、持久和有益的作用”。 在这里阅读更多。
Canada's Large Scale Psilocybin Macrodose Trial
加拿大大规模的 psilocybin 大剂量试验
Canadian biopharma company Apex Labs Ltd., has received Health Canada's approval for a comprehensive, "statistically powered" macro-and-multi dose advanced psilocybin trial on 160 patients.
The trial's primary indication (severe depression within PTSD) is...
加拿大生物制药公司 Apex Labs Ltd. 已获得加拿大卫生部的批...
登录免费看全文
登录/注册